NCT03638336

Brief Summary

In this pilot study, we wish to evaluate the performance of a robotic flexible ureteorscopy (ILY) in the treatment of nephrolithiasis in the superior excretory system

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 20, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

August 5, 2020

Status Verified

August 1, 2020

Enrollment Period

1.3 years

First QC Date

August 16, 2018

Last Update Submit

August 3, 2020

Conditions

Outcome Measures

Primary Outcomes (11)

  • Number of procedures performed entirely using the telemanipulator

    end of study: 3 months

  • Number of procedures where the surgeon had to switch to manual mode or dedock the device

    end of study: 3 months

  • If telemanipulator remained stable during procedure

    Yes/no

    end of procedure; less than 2 hours

  • Time of procedure

    end of procedure; less than 2 hours

  • Docking time

    time between docking of device and use of gamepad

    end of procedure; less than 2 hours

  • Time taken to track kidney stones

    end of procedure; less than 2 hours

  • Time taken for complete exploration of renal cavities

    end of procedure; less than 2 hours

  • Laser fragmentation time

    end of procedure; less than 2 hours

  • Speed of fragmentation

    mm3/minute

    end of procedure; less than 2 hours

  • Any joint pain strain experienced by the surgeon before and after intervention

    binary yes/no

    end of procedure; less than 2 hours

  • Satisfaction of surgeon in using the device

    Custom-made questionnaire with 3 sections measuring: ease of use, ergonomics in exploration of renal cavities and stability during fragmentation of laser

    end of procedure; less than 2 hours

Secondary Outcomes (3)

  • Describe the rate of intra-operative complications during procedure

    end of procedure; less than 2 hours

  • Describe the rate of intra-operative complications

    1 month

  • Integrity of the ureroscope at the end of the procedure

    end of procedure; less than 2 hours

Study Arms (1)

flexible ureteroscopy

EXPERIMENTAL
Device: ILY robotic flexible ureteroscopy

Interventions

fragmentation of nephrolithiasis

flexible ureteroscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old
  • The patient has a single kidney stone in the calyx or the pelvis between 5 and 15mm something to do with a JJ probe
  • Patient has an indication for in situ lithotripsy by supply ureteroscopy

You may not qualify if:

  • The patient is under safeguard of justice or state guardianship
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is pregnant or breastfeeding
  • Patient treated with anticoagulants
  • Documented untreated urinary infection within the previous 48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Nimes

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Stéphane Droupy

    CHU Nimes

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2018

First Posted

August 20, 2018

Study Start

October 1, 2018

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

August 5, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations